MyFinsight
Home
Blog
About
Contact
Download
Download image
Net loss
attributable to lisata...
-$16,586K
(17.01%↑ Y/Y)
Net loss
-$16,586K
(17.01%↑ Y/Y)
Benefit from income
taxes
-$962K
(-20.55%↓ Y/Y)
Investment income, net
$806K
(-57.20%↓ Y/Y)
Corporate Non Segment
$3,026K
(-18.06%↓ Y/Y)
Finance
$2,002K
(-11.61%↓ Y/Y)
Other
$1,921K
(25.07%↑ Y/Y)
Investor
relations/public...
$1,141K
(-14.34%↓ Y/Y)
Share based
compensation expense
$999K
(-27.77%↓ Y/Y)
Legal
$919K
(-28.43%↓ Y/Y)
Business development
$422K
(-27.49%↓ Y/Y)
Clinical Department
$2,999K
(-30.32%↓ Y/Y)
Bolster Trial
$2,540K
(-29.07%↓ Y/Y)
Research And Development
Other
$1,319K
(99.85%↑ Y/Y)
Chemistry Manufacturing
And Controls
$1,050K
(-48.40%↓ Y/Y)
Ascend Trial
$41K
(-94.56%↓ Y/Y)
Net loss before
benefit from income...
-$17,548K
(15.57%↑ Y/Y)
Total other income
$661K
(-59.35%↓ Y/Y)
General and
administrative
$10,430K
(-13.62%↓ Y/Y)
Other expense, net
-$145K
(43.58%↑ Y/Y)
Research and development
$7,949K
(-29.87%↓ Y/Y)
Operating loss
-$18,209K
(18.74%↑ Y/Y)
Revenue
$170K
(-83.00%↓ Y/Y)
Operating loss
-$18,209K
(18.74%↑ Y/Y)
Operating expenses
$18,379K
(-21.49%↓ Y/Y)
General and
administrative
$10,430K
(-13.62%↓ Y/Y)
Research and development
$7,949K
(-29.87%↓ Y/Y)
Back
Back
Income Statement
source: myfinsight.com
LISATA THERAPEUTICS, INC. (LSTA)
LISATA THERAPEUTICS, INC. (LSTA)